Insider · CIK 0001363558
Craig A Collard
Files at HRTX (HERON THERAPEUTICS, INC. /DE/), TSNDF (TerrAscend Corp.). First filing -, latest -.
In brief
Craig A Collard files SEC Form 4 as CEO and director at HRTX (HERON THERAPEUTICS, INC. /DE/), and also at TSNDF (TerrAscend Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Craig A Collard has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 45 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +50,021 | - | - | 821,703 | Aug 3, 2026 |
| Jul 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 856,492 | Aug 3, 2026 |
| Jul 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -50,021 | $0.00 | $0 | 700,295 | Aug 3, 2026 |
| Jul 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 347,886 | Aug 3, 2026 |
| Jul 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 771,682 | Jul 20, 2026 |
| Jul 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 82,781 | Jul 20, 2026 |
| Jun 24, 2026 | TSNDF TerrAscend Corp. | DDisposition to issuer Employee Share Option (Right to Buy)derivative | -150,000 | - | - | 0 | Jun 25, 2026 |
| Jun 24, 2026 | TSNDF TerrAscend Corp. | AGrant or award Employee Share Option (Right to Buy)derivative | +150,000 | - | - | 150,000 | Jun 25, 2026 |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 696,841 | May 4, 2026 |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +50,021 | - | - | 757,885 | May 4, 2026 |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 382,675 | May 4, 2026 |
| Apr 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -50,021 | $0.00 | $0 | 750,316 | May 4, 2026 |
| Apr 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 662,052 | Apr 21, 2026 |
| Apr 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 96,758 | Apr 21, 2026 |
| Apr 3, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +62,500 | - | - | 648,255 | Apr 6, 2026 |
| Apr 3, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -62,500 | $0.00 | $0 | 62,500 | Apr 6, 2026 |
| Jan 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 571,710 | Feb 3, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +800,337 | $0.00 | $0 | 800,337 | Feb 3, 2026 |
| Jan 31, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 417,464 | Feb 3, 2026 |
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Performance Stock Unitsderivative | +800,336 | $0.00 | $0 | 800,336 | Feb 3, 2026 |
| Jan 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 536,921 | Jan 20, 2026 |
| Jan 19, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 110,375 | Jan 20, 2026 |
| Oct 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 523,124 | Nov 4, 2025 |
| Oct 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 452,253 | Nov 4, 2025 |
| Oct 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 488,335 | Oct 21, 2025 |
| Oct 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 124,172 | Oct 21, 2025 |
| Jul 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 474,538 | Aug 4, 2025 |
| Jul 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 487,042 | Aug 4, 2025 |
| Jul 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 439,749 | Jul 22, 2025 |
| Jul 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 137,969 | Jul 22, 2025 |
| Jun 24, 2025 | TSNDF TerrAscend Corp. | AGrant or award Common Shares | +433,653 | $0.00 | $0 | 1,076,538 | Jun 25, 2025 |
| Apr 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +34,789 | - | - | 425,952 | May 2, 2025 |
| Apr 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -34,789 | $0.00 | $0 | 521,831 | May 2, 2025 |
| Apr 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,796 | - | - | 391,163 | Apr 22, 2025 |
| Apr 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,796 | $0.00 | $0 | 151,766 | Apr 22, 2025 |
| Apr 3, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +62,500 | - | - | 377,367 | Apr 3, 2025 |
| Apr 3, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -62,500 | $0.00 | $0 | 125,000 | Apr 3, 2025 |
| Mar 25, 2025 | TSNDF TerrAscend Corp. | FTax withholding Common Shares | -2,258 | $0.46 | $1,039 | 642,885 | Mar 26, 2025 |
| Jan 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Employee Stock Option (Right to Buy)derivative | +1,113,240 | $0.00 | $0 | 1,113,240 | Feb 4, 2025 |
| Jan 31, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Restricted Stock Unitsderivative | +556,620 | $0.00 | $0 | 556,620 | Feb 4, 2025 |
| Jan 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 314,867 | Jan 22, 2025 |
| Jan 19, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 165,562 | Jan 22, 2025 |
| Dec 31, 2024 | TSNDF TerrAscend Corp. | FTax withholding Common Shares | -71,704 | $0.65 | $47k | 645,143 | Jan 3, 2025 |
| Oct 19, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Common Stock | +13,797 | - | - | 290,387 | Oct 21, 2024 |
| Oct 19, 2024 | HRTX HERON THERAPEUTICS, INC. /DE/ | MOption exercise Restricted Stock Unitsderivative | -13,797 | $0.00 | $0 | 179,359 | Oct 21, 2024 |
Questions about Craig A Collard
Answered from the filings on this page, as of the latest one.
Is Craig A Collard buying or selling?
Craig A Collard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Craig A Collard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Craig A Collard has 0.
Where does Craig A Collard file Form 4?
Craig A Collard has filed Form 4 at HRTX (HERON THERAPEUTICS, INC. /DE/) as Chief Executive Officer; TSNDF (TerrAscend Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.